Nuclear transport modulators and uses thereof
US10709706B2 · kind B2 · utility
10Cited by
32References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 30, 2016 |
| Grant date | Jul 14, 2020 |
| Priority date | — |
| Expiry date | Dec 30, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula (I) or their pharmaceutically acceptable salts, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.